ArticleProceedings on Privacy Enhancing Technologies. Privacy Enhancing Technologies Symposium2026
PROVGEN: A Privacy-Preserving Approach for Outcome Validation in Genomic Research.
Article in Proceedings on Privacy Enhancing Technologies. Privacy Enhancing Technologies Symposium, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
As genomic research has grown increasingly popular in recent years, dataset sharing has remained limited due to privacy concerns. This limitation hinders the reproducibility and validation of research outcomes, both of which are essential for identifying computational errors during the research process. In this paper, we introduce PROVGEN, a privacy-preserving method for sharing genomic datasets that facilitates reproducibility and outcome validation in genome-wide association studies (GWAS). Our approach encodes genomic data into binary space and applies a two-stage process. First, we generate a differentially private version of the dataset using an XOR-based mechanism tailored to biological characteristics. Second, we restore data utility by adjusting the Minor Allele Frequency (MAF) values in the noisy dataset to align with public MAFs using optimal transport. Finally, we convert the processed binary data back into its genomic representation and publish the resulting dataset. We evaluate PROVGEN on three real-world genomic datasets and compare it with local differential privacy and three synthesis-based methods. Our results show that PROVGEN overall outperforms existing approaches in detecting GWAS outcome errors, preserving data fidelity, and resisting membership inference attacks (MIAs). By adopting our method, genomic researchers will be inclined to share differentially private datasets while maintaining high data quality for reproducibility of their findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.